For our experiments, we employed lymphoblastoid cell lines obtained from BWS patients with different genetic and epigenetic defects (IC1 GoM, IC2 LoM, or UPD) and healthy pediatric controls previously characterized in our laboratory [33]. Here, DYNC1I2 is linked to Beckwith-Wiedemann syndrome.